DOSSIER · 13F-HR · Q3 2026

Andera Partners

$176M in tracked AUM across 7 positions as of Q3 2026.

AP
CIK 0001757283 · last filed Sep 30, 2026
Total AUM
$176M
as of Q3 2026
Holdings
7
—
positions
Whale Score
69
69
tracked
Activity
—
no data
changes this Q
AI Analysis · Q3 2026

Andera Partners filed its latest 13F-HR for Q3 2026. See the latest holdings and position changes below.

Quarter at a glance — Q3 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q3 2026.

#HoldingValueSharesWeight
01
G52441105
KESTRA MED TECHNOLOGIES LTD
$77M2.7M43.9%
02
MLYS
MINERALYS THERAPEUTICS INC
$40M1.6M22.8%
03
AVLN
AVALYN PHARMACEUTICALS INC
$26M930K15.1%
04
AGMB
AGOMAB THERAPEUTICS NV
$17M1.5M9.7%
05
IVA
INVENTIVA SA
$13M3.6M7.6%
06
EVMN
EVOMMUNE INC
$804K97K0.5%
07
B6S7WD106
NYXOAH S A
$720K522K0.4%

Filing history

2026Q3Sep 30
$176M▼ 14.9%
7 positionsView →
2026Q2Jun 30
$206M▲ 16.7%
8 positionsView →
2026Q1Mar 31
$177M▲ 0.2%
7 positionsView →
2025Q4Dec 31
$177M—
5 positionsView →